Skip to main content
. 2020 Mar 28;9(4):925. doi: 10.3390/jcm9040925

Figure 2.

Figure 2

Subcategory analysis of Sino-Nasal Outcome Test-20 German Adapted Version (SNOT-20 GAV) score in patients suffering from chronic rhinosinusitis without nasal polyps (CRSsNP, blue), chronic rhinosinusitis with nasal polyposis (CRSwNP, green), or chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease (AERD, red). Score for (A, B) Nasal symptoms in (A) all patients and (B) upon the exclusion of patients with documented polyp disease but TPS = 0 (excluded: CRSwNP n = 2; AERD n = 9) are shown in the respective patient groups (x-axis). Bars represent mean values with standard deviation; values of individual patients are depicted as circles (CRSsNP), squares (CRSwNP), or triangles (AERD). Significant differences between patient groups were observed (One-way ANOVA (A) p = 0.0003, (B) p ≤ 0.0001), significant differences in pairwise comparisons using Tukey’s multiple comparison test are indicated (*: p ≤ 0.05; **: p ≤ 0.01; ***: p ≤ 0.001; ****: p ≤ 0.0001, n.s. = not significant).